文献速递糖尿病

严重低血糖对退伍军人事务部糖尿病试验心血管结局与死亡的影响

Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial.
PubMed 文献 · Diabetes Care · 2018-11-19

该研究为VADT事后分析,纳入1791例血糖控制不佳的2型糖尿病退伍军人,随机接受强化(HbA1c<7.0%)或标准(HbA1c<8.5%)降糖治疗。结果显示强化组严重低血糖发生率显著高于标准组(10.3 vs 3.7/100患者年,P<0.001),且近3个月内严重低血糖与严重心血管事件、心血管死亡及全因死亡风险增加相关。

要点

  • 强化降糖组严重低血糖发生率显著高于标准组(10.3 vs 3.7/100患者年)。
  • 基线胰岛素使用、蛋白尿和自主神经病变是严重低血糖独立危险因素。
  • 近3个月严重低血糖与心血管事件、心血管死亡及全因死亡风险增加相关。

核心结论

  • 近3个月内发生严重低血糖与主要心血管事件、心血管死亡及全因死亡风险增加相关,且不受降糖治疗分组影响。
  • 标准治疗组在发生严重低血糖后全因死亡风险进一步增加。

研究设计与样本

  • VADT事后分析,纳入1791例军事退伍军人(年龄60.5±9.0岁),2型糖尿病控制不佳(HbA1c 9.4±2.0%),病程11.5±7.5年。
  • 参与者随机接受强化治疗(HbA1c<7.0%)或标准治疗(HbA1c<8.5%)。

主要发现

  • 强化治疗组严重低血糖发生率为10.3/100患者年,标准治疗组为3.7/100患者年(P<0.001)。
  • 多变量分析中,基线胰岛素使用(P=0.02)、蛋白尿(P=0.009)和自主神经病变(P=0.01)是严重低血糖的独立危险因素,较高BMI具有保护作用(P=0.017)。
  • 近3个月内严重低血糖与严重心血管事件(P=0.032)、心血管死亡(P=0.012)和全因死亡(P=0.024)风险增加相关。
  • 标准治疗组相比强化治疗组,严重低血糖后全因死亡风险增加更显著(P=0.019)。
  • 严重低血糖与心血管事件的关联随总体心血管风险增加而显著增强(P=0.012)。

临床怎么用

  • 对使用胰岛素、合并蛋白尿或自主神经病变的2型糖尿病患者,应警惕严重低血糖风险并加强监测。
  • 发生严重低血糖后应评估心血管风险,尤其标准降糖治疗者需关注全因死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the risk factors for severe hypoglycemia and the association between severe hypoglycemia and serious cardiovascular adverse events and cardiovascular and all-cause mortality in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS: This post hoc analysis of data from the VADT included 1,791 military veterans (age 60.5 ± 9.0 years) with suboptimally controlled type 2 diabetes (HbA1c 9.4 ± 2.0%) of 11.5 ± 7.5 years disease duration with or without known cardiovascular disease and additional cardiovascular risk factors. Participants were randomized to intensive (HbA1c <7.0%) versus standard (HbA1c <8.5%) glucose control. RESULTS: The rate of severe hypoglycemia in the intensive treatment group was 10.3 per 100 patient-years compared with 3.7 per 100 patient-years in the standard treatment group (P < 0.001). In multivariable analysis, insulin use at baseline (P = 0.02), proteinuria (P = 0.009), and autonomic neuropathy (P = 0.01) were independent risk factors for severe hypoglycemia, and higher BMI was protective (P = 0.017). Severe hypoglycemia within the past 3 months was associated with an increased risk of serious cardiovascular events (P = 0.032), cardiovascular mortality (P = 0.012), and total mortality (P = 0.024). However, there was a relatively greater increased risk for total mortality in the standard group compared with the intensive group (P = 0.019). The association between severe hypoglycemia and cardiovascular events increased significantly as overall cardiovascular risk increased (P = 0.012). CONCLUSIONS: Severe hypoglycemic episodes within the previous 3 months were associated with increased risk for major cardiovascular events and cardiovascular and all-cause mortality regardless of glycemic treatment group assignment. Standard therapy further increased the risk for all-cause mortality after severe hypoglycemia.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Davis SN, Duckworth W, Emanuele N, et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care. 2018. PMID: 30455335. doi:10.2337/dc18-1144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。